About
Technology
Issues
FAQ
Links
Official Page
Ruxolitinib for essential thrombocythemia refractory to or intolerant of hydroxyurea: long-term phase 2 study results
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.